Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
PCV Chemotherapy plus Radiation vs Radiation Alone in Anaplastic Oligodendroglioma
NCT00002569Phase 3Completed
- Sponsor
- NRG Oncology
- Start
- Jul 1994
- Primary completion
- Feb 2005
- Modality
- DNA Intercalators/Alkylators, Covalent Small Molecules, Classical Binding Small Molecules
- Countries
- 1
01
Overview
A Phase 3 trial of lomustine, procarbazine, vincristine in anaplastic oligodendroglioma (AO), sponsored by NRG Oncology. Started Jul 1994; status: completed.
02
Drugs
lomustineprocarbazinevincristine
03
Conditions
anaplastic oligodendroglioma (AO)
Beyond the preview
Go deeper on NCT00002569.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00002569.